Track BTC Health Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

BTC Health Limited BTC.AX · Stock Open BTC Health Limited in new tab

0.0580 AUD
P/B
1.77
ROE
-9.92
Beta
-0.20
Loading chart...
Key Metrics
Book Value0.03
Price to Book1.77
Debt/Equity0.66
% Insiders41.760%
Growth
Revenue Growth-0.89%

DCF Valuation

Tweak assumptions to recompute fair value for BTC Health Limited (BTC.AX)
Currency: AUD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

BTC Health Limited Logo BTC Health Limited Analysis (BTC.AX)

Australia Health Care Official Website Stock

Is BTC Health Limited a good investment? BTC Health Limited (BTC.AX) is currently trading at 0.0580 AUD.

Investor FAQ

Does BTC Health Limited pay a dividend?

No, it does not currently pay a dividend.

What asset class is BTC Health Limited?

BTC Health Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cell biology, convergence, silicon biology, and nanomedicine. Within post-genomics, it invests in functional genomics, transcriptomics, proteomics, structural genomics, glycomics, and pharmacogenomics. In the stem cell biology sector, the fund focuses on stem cell therapies. Within convergent technologies, it invests in biomaterials, bionics, biosensors, tissue engineering, microfluidics, and moletronics. In the silicon biology sector, the fund focuses on structure-based drug design, virtual screening, computational library design, and in silico ADME/tox. It invests in companies based in Australia & New Zealand. The fund invests in both listed and unlisted companies.

Exchange Ticker
ASX (Australia) BTC.AX
Trades
Dividend History paid per year (AUD)
Historical Dividends
Year Total Dividends
2012
0.03 AUD
Oct. 19, 2012 0.0100
Oct. 18, 2012 0.0154
2011
0.09 AUD
July 15, 2011 0.0616
May 16, 2011 0.0308
2010
0.03 AUD
Sept. 13, 2010 0.0308
2001
0.01 AUD
Oct. 10, 2001 0.0114
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion